U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07500012) titled 'taVNS for Breast Cancer Pain and Symptom Management' on March 22.

Brief Summary: 1. To evaluate the feasibility and acceptability of a home-based taVNS intervention and follow-up for pain and symptom management in breast cancer survivors.

2. To investigate the impact of taVNS on secondary outcomes, including pain, anxiety, depression, fatigue, and the brain-gut axis (BGA) in breast cancer survivors.

Study Start Date: Feb. 24

Study Type: INTERVENTIONAL

Condition: Breast Cancer Survivors

Intervention: DEVICE: Active taVNS

practice the active taVNS twice daily for 30 minutes each over a 4-week period (56 sessions)

DEVICE: Sha...